Day: September 22, 2020

Tesla’s big announcement on batteries has the potential to shape the future of electric cars

It’s the latest innovation push by the Silicon Valley car builder that has aimed to rewrite the rules on electric vehicles, making them performance-oriented and aspirational in a way that has eluded competitors. But electric vehicles constitute a small slice of the overall car market, and to expand, Tesla will need to reign supreme over not only the manufacturing of vehicles but also their lifeblood: batteries. Elon Musk plans to announce Tesla’s plans for tackling that issue at a widely anticipated “Battery Day” event Tuesday.

“Today, [electric vehicles] account for about 3% of cars sold globally,” Gene Munster, an investor and managing partner of Loup Ventures, wrote in an analyst note ahead of the event. “Tesla has an opportunity to parlay its current 80% [electric vehicle] market share in the US, along with about 20% in Europe and Asia, into a massive business in the years to come. To be

Read More

Cynicism suggests that the TikTok deal will go through

Mark Twain is credited with first saying that if you don’t like the weather in New England, just wait five minutes. The TikTok deal has followed a similar schedule.

On Friday, President Trump said downloads of TikTok would be banned from mobile app stores on Sunday, potentially preventing users from receiving critical security updates.

On Saturday, Trump said he supported Oracle’s bid to acquire a stake in TikTok and oversee some of its operations, and extended the ban date to September 27th. As part of the deal, he said, the companies involved had agreed to contribute $5 billion for “patriotic education.”

On Sunday, everyone involved took a well deserved rest. And as Monday dawned, everything went to hell.

Everyone agrees that Oracle and Walmart have bought a combined 20 percent of TikTok. But the remaining 80 percent appears to be up for grabs. Here are Georgia Wells and Alex Leary

Read More

New PET Scanner Offers Improved Diagnosis At Emory Johns Creek

JOHNS CREEK, GA — Emory Johns Creek Hospital is the first facility in Georgia to offer patients access to the first mobile, advanced digital positron emission tomography (PET) molecular imaging technology.

The uMI 550 is a state-of-the-art digital PET/CT (computed tomography) scanner that delivers faster scan times, reduced radiation doses and enhanced visualization of small lesions with exceptional image quality.

“As a leader in diagnostic imaging, Emory Healthcare is providing patients advanced digital positron emission tomography or PET molecular imaging for individuals in the Northern Arc serviced by Emory Johns Creek Hospital,” says David Schuster, MD, FACR, professor and director, Division of Nuclear Medicine and Molecular Imaging, Emory University School of Medicine.

“The technology will facilitate the use of more progressive PET studies, including those for prostate cancer and neuroendocrine tumors.”

The new equipment adds to the ongoing improvements at Emory Johns Creek Hospital and Winship Cancer Institute of Emory

Read More

Why now is the most exciting time in space in 50 years

The essential parts of an economy are intertwined by their very nature. There’s no point in having a food market if there are no farmers to supply food. But there’s no point in growing food until there are markets where you can sell it. And what is the right moment to go into the “food transportation” business, carting the freshly harvested produce from the field to the store? We’ve seen this in our own era: What was the point in creating high-speed internet service if there was no content online that required such speeds? Why bother creating YouTube if no one has the bandwidth to watch and upload videos easily?

This is exactly the moment we’re in with human space travel. Why bother creating the technology to launch people into space when there’s nowhere in particular to go? But why create destinations in space when there’s no affordable way to

Read More

Forex technical analysis and forecast: Majors, equities and commodities

EUR/USD, “Euro vs US Dollar”

After breaking 1.1830 to the downside and then reaching 1.1731, EURUSD is consolidating above the latter level. Possibly, the pair may correct towards 1.1794 and then resume trading within the downtrend with the short-term target at 1.1720.


GBP/USD, “Great Britain Pound vs US Dollar”

After breaking 1.2900 to the downside and then reaching 1.2800, GBPUSD is consolidating around the latter level. Today, the pair may correct to reach 1.2868 and then continue moving inside the downtrend with the target at 1.2742.


USD/RUB, “US Dollar vs Russian Ruble”

After breaking 75.55 to the upside and then reaching 76.55, USDRUB is consolidating near the highs. Possibly, today the pair may expand the range up to 76.65 and resume trading downwards with the target at 74.74.


USD/JPY, “US Dollar vs Japanese Yen”

USDJPY has finished the correctional structure to test 104.81 from below. Today, the pair may resume

Read More

Willow, the startup making the wearable breast pump, raises $55 million

Willow, the startup company making a new, wearable, breast pump for women, is capping off a frenetic 2020 with $55 million in fresh funding as it looks to expand its product line to more offerings for new mothers.

The company is coming off a year which saw sales increase, and Laura Chambers, the former eBay and Airbnb manager, take over as chief executive and now, with the new capital, it expects to be bringing new products to market beyond the breast pump in 2021.

A March 2020 report from Frost & Sullivan put the total size of the femtech market, including technologies for mothers, at just over $1 billion with growth rates of 12.9%. So the category is small, but growing quickly as more tools come in to provide services in what is a woefully underinvested sector. Indeed, the $155 million that Willow has raised to date puts the company

Read More

Computer Aided Detection (CAD) Market to See Huge Growth in Next 5 Years: GE Healthcare, Siemens Healthcare, Philips Healthcare

The MarketWatch News Department was not involved in the creation of this content.

Sep 22, 2020 (Market Insight Reports) —
(New Jersey) A new business intelligence report released by HTF MI with title “Global Computer Aided Detection (CAD) Market Professional Survey Report 2019” is designed covering micro level of analysis by manufacturers and key business segments. The Global Computer Aided Detection (CAD) Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are EDDA Technology, Inc., GE Healthcare, Siemens Healthcare, Fujifilm Medical Systems USA, Inc., Toshiba Medical Systems Corporation, Hologic, Inc., iCAD, Inc., Invivo Corporation, Philips Healthcare, McKesson Corporation, Agfa-Gevaert N.V., Merge Healthcare, Inc., Riverain Technologies, Salient Imaging, Inc. & VuCOMP Inc.

What’s keeping EDDA Technology,

Read More

‘We’ve seen people going down right and left’: Dax Hollifield gets candid about Tech’s battle with COVID-19 | Virginia Tech

“It’s pretty weird,” Hollifield said. “You are not really sick or anything and they call your name. Yup, you tested positive, you have to do this, this and this and can’t be around football for two weeks. It sucks. It really does. It’s the way we have to do it. It’s the world we live in right now, so you gotta get through it.”

According to the ACC’s coronavirus medical guidelines, student-athletes who test positive are not subject to weekly pre-competition testing for 90 days from the date of their positive test unless they show symptoms.

Hollifield won’t have that added layer of uncertainty in the coming weeks, but things aren’t back to normal yet for a Virginia Tech team that’s still worried about the number of players that will be available this weekend against NC State.

Tech coach Justin Fuente made that clear when he said not everyone listed

Read More

Intel Appoints Saf Yeboah-Amankwah as Senior Vice President and Chief Strategy Officer

[September 22, 2020]

Intel Appoints Saf Yeboah-Amankwah as Senior Vice President and Chief Strategy Officer

Intel (News – Alert) Corporation today announced the appointment of Safroadu (Saf) Yeboah-Amankwah as senior vice president and chief strategy officer, effective Nov. 1. Yeboah-Amankwah will be responsible for the global strategy office, including Intel Capital (News – Alert), and will work with the executive team on developing and driving growth-oriented strategies. Yeboah-Amankwah will report to CEO Bob Swan.

This press release features multimedia. View the full release here:

Safroadu (Saf) Yeboah-Amankwah was named senior vice president and chief strategy officer at Intel Corporation in September 2020. (Photo: Business Wire)

Safroadu (Saf) Yeboah-Amankwah was named senior vice president and chief strategy officer at Intel Corporation in September 2020. (Photo: Business Wire)

“A profound evolution in computing is opening a much larger opportunity with implications for every aspect of our business,” said Swan. “Saf has strong experience in strategy and international markets, a deep technical background, and he knows Intel well. He is an excellent

Read More

Future of CGM Technology Looks Bright

Individuals with diabetes, whether its type 1 or type 2, must check their blood sugar regularly to keep that and their A1c levels monitored and under control.

Some patients test once a day, some more than 6 times a day. Pricking their fingers many times, can present a challenge for patients. Some have issues with compliance and remembering to test, some are scared of the pain from finger pricking, and others have trouble arranging their daily activities and chores around testing their blood sugar levels and managing the disease.

In recent years, many improvements have occurred in terms of testing blood sugars. It started in the 1800s when there were attempts to quantify glucose levels in the urine. This created the basis for testing blood sugars for patients with diabetes. In 1908, for the first time, the Benedict urine glucose copper reagent was developed, becoming the go-to test for next

Read More